한글목차

처방전 진통제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 772억 2,000만 달러에서 2026년에는 813억 6,000만 달러에 이르고, CAGR 5.4%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 만성통증의 고빈도 발생, 오피오이드 처방약의 보급, 수술 건수 증가, 고령화 사회 진입, 암성 통증 환자 증가 등을 꼽을 수 있습니다.

처방 진통제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,001억 6,000만 달러에 이르고, CAGR은 5.3%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 보다 안전한 통증 치료법 개발, 신경병증성 통증 발생률 증가, 외래 진료 확대, 디지털 처방 플랫폼 확산, 오피오이드 규제 강화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 비오피오이드 기반 통증 관리로의 전환, 만성 통증 치료법에 대한 수요 증가, 경피흡수성 및 지속성 약물의 성장, 디지털 및 온라인 약국 확대, 오피오이드에 대한 규제 당국의 감시 강화 등을 꼽을 수 있습니다.

관절염의 유병률 증가는 향후 몇 년 동안 처방 진통제 시장의 성장을 가속할 것으로 예측됩니다. 관절염은 하나 이상의 관절에 염증이 생겨 통증, 부종, 뻣뻣함, 운동 범위의 제한을 유발하는 질환입니다. 그 유병률 증가는 주로 비만과 관련이 있으며, 과도한 체중이 관절(특히 무릎)에 추가적인 부담을 가하고 염증을 촉진하기 때문입니다. 처방 진통제는 통증과 염증을 줄이고 관절 기능을 개선하며 환자의 삶의 질을 향상시켜 관절염 관리를 돕습니다. 예를 들어, 2024년 1월 영국 정부 기관인 건강 개선 및 격차 대책국이 발표한 데이터에 따르면, 2023년 16세 이상 인구의 18.4%가 장기 근골격계(MSK) 질환을 앓고 있으며, 이는 2022년 17.6%에서 증가한 수치입니다. 따라서, 관절염 유병률 증가는 처방 진통제 시장의 성장을 주도하고 있습니다.

처방용 진통제 시장에서 사업을 영위하는 주요 기업들은 오피오이드 중독에 대한 우려에 대응하고 환자의 안전성을 향상시키기 위해 비오피오이드 계열 진통제 등 대체 요법 개발에 집중하고 있습니다. 비오피오이드 계열 진통제는 오피오이드에 수반되는 의존성 위험 없이 통증을 관리하고, 중독 및 과다복용 가능성을 낮추면서 장기적인 통증 관리를 위한 보다 안전하고 효과적인 대안을 제공합니다. 예를 들어, 2025년 1월, 미국 바이오테크놀러지 기업 버텍스 파마슈티컬스(Vertex Pharmaceuticals)는 FDA의 승인을 받은 최초의 비오피오이드 경구용 약물인 'JOURNAVX'에 대한 승인을 받았습니다. 이 약은 말초신경의 NaV1.8 나트륨 채널을 선택적으로 차단하여 중추신경계를 통하지 않고 통증 신호를 억제하여 의존성 위험 없이 효과적인 급성 통증 완화를 제공합니다. 복부 성형술 및 외반족 수술에 대한 3상 임상시험에서 1일 2회 투여 요법으로 임상적으로 유의미한 통증 감소를 확인했으며, 이 약은 규제 약물에 해당하지 않습니다. 이를 통해 보다 안전한 급성 통증 관리에 대한 중요한 니즈에 대응하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare professional to manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when non-prescription options are insufficient to control pain.

The main types of prescription pain medications include prescription non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-epileptic drugs, antidepressants, and other categories. Prescription NSAIDs are medications provided by healthcare professionals to reduce inflammation, alleviate pain, and lower fever by inhibiting cyclooxygenase (COX) enzymes. These drugs can be administered via various routes, including oral, injectable, transdermal, and others. They are used to treat a variety of conditions such as neuropathic pain, cancer pain, post-operative pain, and more. Distribution occurs through hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have affected the prescription pain medication market by increasing costs of active pharmaceutical ingredients and excipients, especially for opioid and NSAID formulations. North America and Asia-Pacific have experienced supply delays due to cross-border trade restrictions. On the positive side, tariffs have driven domestic API manufacturing and encouraged diversification of sourcing strategies to reduce long-term dependency on imports.

The prescription pain medication market research report is one of a series of new reports from The Business Research Company that provides prescription pain medication market statistics, including prescription pain medication industry global market size, regional shares, competitors with a prescription pain medication market share, detailed prescription pain medication market segments, market trends and opportunities, and any further data you may need to thrive in the prescription pain medication industry. This prescription pain medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prescription pain medication market size has grown strongly in recent years. It will grow from $77.22 billion in 2025 to $81.36 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to high prevalence of chronic pain, widespread opioid prescriptions, increasing surgical procedures, aging population, growth in cancer pain cases.

The prescription pain medication market size is expected to see strong growth in the next few years. It will grow to $100.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to development of safer pain therapies, rising neuropathic pain incidence, expansion of outpatient care, digital prescription platforms, stricter opioid regulations. Major trends in the forecast period include shift toward non-opioid pain management, rising demand for chronic pain therapies, growth of transdermal and long-acting drugs, expansion of digital and online pharmacies, increased regulatory scrutiny on opioids.

The rising prevalence of arthritis is expected to drive the growth of the prescription pain medication market in the coming years. Arthritis is a condition characterized by inflammation of one or more joints, resulting in pain, swelling, stiffness, and reduced range of motion. Its increasing prevalence is largely linked to obesity, as excess body weight places additional stress on joints-particularly the knees-and promotes inflammation. Prescription pain medications support arthritis management by reducing pain and inflammation, improving joint function, and enhancing overall quality of life for affected individuals. For example, in January 2024, data from the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2023, 18.4% of people aged 16 and over had a long-term musculoskeletal (MSK) condition, up from 17.6% in 2022. Therefore, the growing prevalence of arthritis is driving the growth of the prescription pain medication market.

Major companies operating in the prescription pain medication market are focusing on developing alternative therapies, such as non-opioid painkillers, to address concerns over opioid addiction and improve patient safety. Non-opioid painkillers manage pain without the addictive risks associated with opioids, providing safer and effective options for long-term pain management while reducing the potential for addiction and overdose. For instance, in January 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, received FDA approval for JOURNAVX, a first-in-class non-opioid oral medication. This drug selectively blocks NaV1.8 sodium channels in peripheral nerves to inhibit pain signals without involving the central nervous system, offering effective acute pain relief without addictive potential. Phase 3 trials in abdominoplasty and bunionectomy demonstrated clinically meaningful pain reduction with a twice-daily dosing regimen, and the medication is not a controlled substance, addressing a critical need for safer acute pain management.

In January 2024, Heron Therapeutics Inc., a US-based biotechnology company, partnered with CrossLink Life Sciences, LLC to expand the sales network for its extended-release local anesthetic, ZYNRELEF. Through this partnership, Heron and CrossLink aim to add approximately 650 sales representatives and promote broader adoption of ZYNRELEF, particularly in orthopedic surgery for post-operative pain management. CrossLink Life Sciences LLC is a US-based company specializing in orthopedic, spine, and sports medicine devices.

Major companies operating in the prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc

North America was the largest region in the prescription pain medication market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription pain medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prescription pain medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription pain medication market consists of sales of acetaminophen, antidepressants, anticonvulsants, muscle relaxants, and biologic pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription Pain Medication Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses prescription pain medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription pain medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prescription pain medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs; Opioids; Anti-Epileptic Medicines; Antidepressants; Other Types
• 2) By Route Of Administration: Oral; Injectable; Transdermal; Other Route Of Administrations
• 3) By Application: Neuropathic Pain; Cancer Pain; Post-Operative Pain; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors; Traditional Non-Steroidal Anti-Inflammatory Drugs; Combination Non-Steroidal Anti-Inflammatory Drugs
• 2) By Opioids: Strong Opioids; Mild Opioids; Opioid Combination Medications
• 3) By Anti-Epileptic Medicines: Sodium Channel Blockers; Gamma-Aminobutyric Acid Modulators; Glutamate Inhibitors
• 4) By Antidepressants: Selective Serotonin Reuptake Inhibitors; Tricyclic Antidepressants; Serotonin-Norepinephrine Reuptake Inhibitors; Other Antidepressants
• 5) By Other Types: Muscle Relaxants; Topical Pain Medications; Corticosteroids
• Companies Mentioned: Mallinckrodt Public Limited Company; Pfizer Inc.; Johnson And Johnson; Merck And Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Novartis International AG; GlaxoSmithKline Public Limited Company; Takeda Pharmaceutical Company Limited; Eli Lilly And Company; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim GmbH; Mylan N.V.; Sandoz Inc; Bausch Health Companies Inc.; Purdue Pharma L.P.; Endo International Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Prescription Pain Medication Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Prescription Pain Medication Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Prescription Pain Medication Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Prescription Pain Medication Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
• 4.2. Major Trends
  • 4.2.1 Shift Toward Non-Opioid Pain Management
  • 4.2.2 Rising Demand For Chronic Pain Therapies
  • 4.2.3 Growth Of Transdermal And Long-Acting Drugs
  • 4.2.4 Expansion Of Digital And Online Pharmacies
  • 4.2.5 Increased Regulatory Scrutiny On Opioids

5. Prescription Pain Medication Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Pain Management Centers
• 5.4 Home Healthcare Providers
• 5.5 Pharmacies

6. Prescription Pain Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Prescription Pain Medication Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Prescription Pain Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Prescription Pain Medication Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Prescription Pain Medication Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Prescription Pain Medication Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Prescription Pain Medication Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Prescription Pain Medication Market Segmentation

• 9.1. Global Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prescription Non-Steroidal Anti-Inflammatory Drugs, Opioids, Anti-Epileptic Medicines, Antidepressants, Other Types
• 9.2. Global Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Injectable, Transdermal, Other Route Of Administrations
• 9.3. Global Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neuropathic Pain, Cancer Pain, Post-Operative Pain, Other Applications
• 9.4. Global Prescription Pain Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Prescription Pain Medication Market, Sub-Segmentation Of Prescription Non-Steroidal Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• COX-2 Inhibitors, Traditional Non-Steroidal Anti-Inflammatory Drugs, Combination Non-Steroidal Anti-Inflammatory Drugs
• 9.6. Global Prescription Pain Medication Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Strong Opioids, Mild Opioids, Opioid Combination Medications
• 9.7. Global Prescription Pain Medication Market, Sub-Segmentation Of Anti-Epileptic Medicines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sodium Channel Blockers, Gamma-Aminobutyric Acid Modulators, Glutamate Inhibitors
• 9.8. Global Prescription Pain Medication Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, Other Antidepressants
• 9.9. Global Prescription Pain Medication Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Muscle Relaxants, Topical Pain Medications, Corticosteroids

10. Prescription Pain Medication Market Regional And Country Analysis

• 10.1. Global Prescription Pain Medication Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Prescription Pain Medication Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Prescription Pain Medication Market

• 11.1. Asia-Pacific Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Prescription Pain Medication Market

• 12.1. China Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Prescription Pain Medication Market

• 13.1. India Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Prescription Pain Medication Market

• 14.1. Japan Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Prescription Pain Medication Market

• 15.1. Australia Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Prescription Pain Medication Market

• 16.1. Indonesia Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Prescription Pain Medication Market

• 17.1. South Korea Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Prescription Pain Medication Market

• 18.1. Taiwan Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Prescription Pain Medication Market

• 19.1. South East Asia Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Prescription Pain Medication Market

• 20.1. Western Europe Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Prescription Pain Medication Market

• 21.1. UK Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Prescription Pain Medication Market

• 22.1. Germany Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Prescription Pain Medication Market

• 23.1. France Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Prescription Pain Medication Market

• 24.1. Italy Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Prescription Pain Medication Market

• 25.1. Spain Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Prescription Pain Medication Market

• 26.1. Eastern Europe Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Prescription Pain Medication Market

• 27.1. Russia Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Prescription Pain Medication Market

• 28.1. North America Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Prescription Pain Medication Market

• 29.1. USA Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Prescription Pain Medication Market

• 30.1. Canada Prescription Pain Medication Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Prescription Pain Medication Market

• 31.1. South America Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Prescription Pain Medication Market

• 32.1. Brazil Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Prescription Pain Medication Market

• 33.1. Middle East Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Prescription Pain Medication Market

• 34.1. Africa Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Prescription Pain Medication Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Prescription Pain Medication Market Regulatory and Investment Landscape

36. Prescription Pain Medication Market Competitive Landscape And Company Profiles

• 36.1. Prescription Pain Medication Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Prescription Pain Medication Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Prescription Pain Medication Market Company Profiles
  • 36.3.1. Mallinckrodt Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Prescription Pain Medication Market Other Major And Innovative Companies

• Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc

38. Global Prescription Pain Medication Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Prescription Pain Medication Market

40. Prescription Pain Medication Market High Potential Countries, Segments and Strategies

• 40.1 Prescription Pain Medication Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Prescription Pain Medication Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Prescription Pain Medication Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer